Daiichi SankyoDAIICHI SANKYO COMPANY, LIMITED4568東証プライム医薬品FY ending Mar 2024, consolidated, IFRS
Daiichi Sankyo brought in ¥955.1B in revenue.
※ Cost of revenue is not disclosed; expenses are combined
※ Operating income is not disclosed; the chart goes straight to pretax income including investment gains
A machine-readable operating income value exists, but it is not in the validated published data, so the chart is omitted.
EDINET (FSA Japan)
有価証券報告書－第16期(令和2年4月1日－令和3年3月31日)
Extracted from XBRL: 17 / Derived from other figures: 1
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.